Alzheimer's Drug Meant To Slow Disease Becomes More Accessible to Americans After Getting FDA's Full Approval | HNGN
The FDA approved Leqembi for people with early Alzheimer's disease on Thursday, making it easier for older adults to obtain the first drug to slow memory and thinking issues.